Truthout
FDA

FDA Still Struggles to Inspect Foreign Drug Manufacturers After COVID Delays
A series of deaths linked to bacteria-tainted eyedrops produced overseas has raised alarm over a lag in FDA inspections.

SCOTUS: Mifepristone to Remain Available Without Tightened Restrictions, for Now
The drug, used for self-medicated abortions up to the 10th week, may be distributed by mail until 11:59 PM ET Friday.

Judge Who Ruled on Abortion Pill Was Handpicked by Network That Brought Lawsuit
His nomination was part of a broader project championed by his former boss, a member of the Council for National Policy.

Right-Wing Appeals Court Judges Allow Abortion Pill Limits to Take Effect
The decision upheld part of a ruling that halted the FDA’s decision allowing mifepristone to be distributed by mail.

Biden White House Rejects Progressive Demands to Ignore Abortion Pill Ruling
Should the ruling be upheld, the entire FDA approval process could be placed at the mercy of right-wing judges.

AOC Calls on Biden to Ignore Mifepristone Ruling, Resist “National Abortion Ban”
Ocasio-Cortez called Friday's decision invalidating the FDA's approval of the abortion pill “an extreme abuse of power.”

Narcan No Longer Needs a Prescription, But Its Price Tag Could Limit Access
The FDA’s decision sends the right public health message but does not make Narcan affordable for everyone.

SCOTUS Denies Steven Donziger’s Request for Appeal of Conviction in Chevron Case
The move could have implications for the pending ruling regarding the FDA’s approval of a common abortion drug.

Why Won’t the FDA Adopt a Truly Bold Playbook on Medication Abortion?
Abortion pills are safer than Tylenol, but the FDA is keeping unnecessary barriers to access in place.

COVID Boosters Are Critical, But Using Only Animal Data Is a Needless Gamble
FDA’s reliance on animal-tested data ahead of a planned Fall 2022 booster rollout is nothing short of cutting corners.